Drugs@FDA document

OPTIVAR Review · NDA 021127 ORIG-1

Drugs@FDA document · RISING · May 22, 2002

Key facts

Drug name OPTIVAR
Document type Review
Application NDA021127
Submission ORIG-1
Company RISING
Document date May 22, 2002
FDA document accessdata.fda.gov

At a glance

  • Chemistry Review Document categories
  • 10–99 Documents for this application

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents